Other edema specific to newborn
ICD-10 P83.39 is a billable code used to indicate a diagnosis of other edema specific to newborn.
P83.39 refers to other forms of edema that can occur in newborns, which may not fit into more specific categories. One notable condition associated with this code is sclerema neonatorum, a rare but serious condition characterized by hardening of the skin and subcutaneous tissues in newborns. This condition typically presents within the first few days of life and is often associated with prematurity, low birth weight, and underlying infections or metabolic disorders. The skin appears tense and indurated, primarily affecting the extremities and trunk. The pathophysiology involves an abnormal accumulation of collagen and other extracellular matrix components, leading to the characteristic hardening. Management of sclerema neonatorum focuses on supportive care, addressing any underlying conditions, and monitoring for complications. Accurate coding for P83.39 requires careful documentation of the clinical presentation and any associated conditions to ensure appropriate reimbursement and care continuity.
Detailed clinical notes on the infant's condition, including onset, progression, and any interventions.
Infants presenting with hardening skin in the NICU, particularly those with low birth weight or prematurity.
Consideration of the infant's gestational age and overall health status is crucial for accurate coding.
Thorough history and physical examination notes, including family history and any relevant prenatal factors.
Pediatric follow-ups for infants previously diagnosed with sclerema neonatorum.
Awareness of the long-term implications of sclerema on growth and development.
Used when managing a newborn with sclerema neonatorum in the NICU.
Detailed notes on the infant's condition, interventions, and response to treatment.
Neonatologists should ensure comprehensive documentation to support critical care coding.
Accurate coding of P83.39 is crucial for appropriate reimbursement, tracking of neonatal conditions, and ensuring that infants receive the necessary care and follow-up for conditions like sclerema neonatorum.
